Updates arrive automatically.
Modal Raises $750 Million in Series D Round: NYSE Content Update Guidewire Delivers the Open, Secure, and Complete Core Platform for Agentic Insurance PR··TechnologyGuidewire Delivers the Open, Secure, and Complete Core Platform for Agentic Insurance
Insurers gain speed and precision across the insurance lifecycle to launch products faster, assess and price risk more effectively, and resolve claims sooner
Ahead of a January 2027 Pentagon Sourcing Rule, Tungsten Projects Outside China Move Into Permits and Restarts PR··Basic MaterialsAhead of a January 2027 Pentagon Sourcing Rule, Tungsten Projects Outside China Move Into Permits and Restarts
Equity Insider News Commentary - China produced an estimated 67,000 of the world’s 85,000 metric tons of mined tungsten in 2025, according to the U.S. Geological Survey (USGS), which also reports that China ranked first in the world in tungsten resources and reserves. The USGS lists no U.S. mine production for either 2024 or 2025. With a Pentagon sourcing restriction set to reach back to the mine on January 1, 2027, companies in the U.S. and allied countries are moving tungsten and other critical-mineral projects through permitting, restarts and new funding. Companies mentioned in today’s commentary include: Western Star Resour
LPL Financial Welcomes Advisor Matt Griggs PR··FinanceLPL Financial Welcomes Advisor Matt Griggs
LPL Financial LLC announced today that financial advisor Matt Griggs, AAMS®, CRPC™, of Griggs Investment Group has joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platforms. Griggs reported serving approximately $160 million in advisory, brokerage and retirement plan assets* and joins LPL from Edward Jones. Based in Eufaula, Alabama, Griggs serves individuals and families across generations, including clients in the agricultural community and government employees navigating workplace retirement plan distributions. His clients span a wide range of ages, and his practice includes multigenerational relationships that h
Kaplan Survey: Almost All Medical School Admissions Officers Expect Fierce Competition to Continue, With a Strong MCAT® Score as Key to Success PR··Real EstateKaplan Survey: Almost All Medical School Admissions Officers Expect Fierce Competition to Continue, With a Strong MCAT® Score as Key to Success
Nearly all U.S. medical schools (94 percent) polled predict that the 2026–2027 admissions cycle will be at least as competitive as the 2025-2026 cycle, according to a new survey from global education company Kaplan.* This includes 6 percent who expect admissions to be much more competitive, 44 percent who anticipate somewhat greater competition, and 44 percent who believe competitiveness will remain about the same. Just 2 percent predict a less competitive cycle; and 4 percent aren’t sure. The findings come as the number of medical school applicants continues to rise. According to the Association of American Medical Colleges, 54,699 aspiring doctors applied to U.S. MD-granting medical sch
XP downgraded by Citigroup with a new price target ANALYST··FinanceXP downgraded by Citigroup with a new price target
Citigroup downgraded XP from Buy to Neutral and set a new price target of $15.00
VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide PR··Health CareVolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has executed a non-binding Letter of Intent ("LOI") with Missionpharma A/S, a Danish global leader in the sale and distribution of healthcare products and innovative solutions, impacting the lives of over 100 million patients annually, regarding the potential development and launch of Volition's prototype Lateral Flow Technology ("LFT") for NETosis. Dr. Gaetan Michel, Chief Operating Officer, Volition, commented:"We recently announced a major technical milestone: results utilizing our lateral flow prototype are highly correlated with result
PagSeguro Digital downgraded by Citigroup with a new price target ANALYST··TechnologyPagSeguro Digital downgraded by Citigroup with a new price target
Citigroup downgraded PagSeguro Digital from Buy to Neutral and set a new price target of $8.00
NYSE: MMA – MMA.INC Reports Double Digit Quarterly BJJLink Growth; Annualized Transaction Volume Reaches US$25.4M PR··Consumer DiscretionaryNYSE: MMA – MMA.INC Reports Double Digit Quarterly BJJLink Growth; Annualized Transaction Volume Reaches US$25.4M
Student profiles increased 12.4%, verified gyms 14.0% and monthly check-ins 17.6% from June to September, with September check-in activity equivalent to 1.17 million on an annualized basis. Highlights Monthly student check-ins increased 17.6% from June to September to 97,195, equivalent to 1.17 million annualized check-ins. Verified gyms increased 14.0% during the quarter to 1,148. Registered student profiles grew 12.4% during the quarter to 120,048. September transaction volume reached US$2.11 million, representing US$25.4 million annualized, compared with the US$21 million annualized figure previously reported
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics PR··Health CarePyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced a late-breaking oral presentation on micvotabart pelidotin (MICVO) monotherapy in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, to take place in Barcelona, Spain, November 18 - November 20, 2026. In addition, Pyxis Oncology will present two posters highlighting preclinical research involving MICVO during the symposium’s antibody-drug conjugates session. Oral Presentatio
Conduent to Report Third-Quarter 2026 Financial Results on November 5, 2026 PR··Real EstateConduent to Report Third-Quarter 2026 Financial Results on November 5, 2026
Conduent Incorporated (NASDAQ:CNDT), a global technology-enabled operating partner, plans to report its third-quarter 2026 financial results on Thursday, November 5 after market close. Management will present the results during a conference call and webcast at 4:30 p.m. ET. The call will be available by live audiocast along with the news release and online presentation slides at https://investor.conduent.com The conference call will also be available by calling 800-717-1738 toll free. The international dial-in is +1-646 307 1865. If requested, the conference ID is 13763477. A recording of the conference call with be available by calling 877-660-6853 or 201-612-7415 after the conferenc
Blackstone Launches Senior Notes Offering PR··FinanceBlackstone Launches Senior Notes Offering
Blackstone (NYSE:BX) today announced its intention to offer, subject to market and other conditions, senior notes of Blackstone Reg Finance Co. L.L.C., its indirect subsidiary. The notes are to be fully and unconditionally guaranteed by Blackstone Inc. and its indirect subsidiaries, Blackstone Holdings I L.P., Blackstone Holdings AI L.P., Blackstone Holdings II L.P., Blackstone Holdings III L.P. and Blackstone Holdings IV L.P. Blackstone intends to use the proceeds from the notes offering for general corporate purposes. The notes are being offered pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission (the "SEC") and only by means of a p
Progressive Announces Investor Relations Call PR··FinanceProgressive Announces Investor Relations Call
As previously announced, The Progressive Corporation (NYSE:PGR) will host an Investor Relations conference call on Tuesday, November 3, 2026, beginning at 9:30 a.m. eastern time. This quarterly call, which will consist of both a conference call and audio-only webcast, is scheduled to last 60 minutes and will consist of a question-and-answer session with Tricia Griffith, our CEO, and Andrew Quigg, our CFO. Call-in participants will be able to ask questions via phone, however, webcast participants will not be able to submit questions online. On November 2, 2026, Progressive expects to file its Quarterly Report on Form 10-Q with the S
IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation PR··Health CareIceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
First patient enrolled and treated at
Critical Metals Corp. Acquisition of European Lithium Becomes Effective PR··Basic MaterialsCritical Metals Corp. Acquisition of European Lithium Becomes Effective
Critical Metals Corp. (NASDAQ:CRML) ("Critical Metals Corp" or the "Company"), a leading critical minerals exploration and mining company, today announced that the schemes of arrangement for its proposed acquisition of European Lithium Limited ((ASX: EUR, FRA: PF8, OTC:EULIF) ("European Lithium") have become legally effective. Under the proposed transaction, Critical Metals Corp would acquire 100% of the issued share capital of European Lithium and all of European Lithium’s listed options by way of Court-approved schemes of arrangement under Part 5.1 of the Australian Corporations Act 2001 (Cth), comprising a scheme between European Lithium and
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th PR··Health CareEnvoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it will report its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day. Third Quarter 2026 Financial Results Conference Call:Date: Thursday, November 5, 2026Time: 4:30 P.M. ETLive Call: 1-800-267-6316 (U.S. Toll Free) or 1
WF Holding Limited Announces Share Consolidation PR··Consumer DiscretionaryWF Holding Limited Announces Share Consolidation
WF Holding Limited (NASDAQ:WFF) (the "Company"), today announced that it will effect a share consolidation of its ordinary shares, par value $0.00025 per share, at a ratio of 1-for-25, effective on October 30, 2026 (the "Share Consolidation"). The Company's ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on October 30, 2026. Upon the market opening on October 30, 2026, the Company's ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol "WFF" with the new CUSIP number G9627R123. Prior to the Share Consolidation, 149,398,598 ordinary shares, consi
Allergan Aesthetics Announces 2026 Grant Recipients of The Confidence Collective, Funded by BOTOX® Cosmetic (onabotulinumtoxinA) PR··Health CareAllergan Aesthetics Announces 2026 Grant Recipients of The Confidence Collective, Funded by BOTOX® Cosmetic (onabotulinumtoxinA)
Since its inception, The Confidence Collective has supported more than 500 women entrepreneurs and awarded more than $1.5 million in grants to fuel business growth and empower confidence. In 2026 alone, BOTOX® Cosmetic awarded 20 women entrepreneurs each with a $20,000 grant to help advance their business goals.
Flux Power to Host 2027 Fiscal First Quarter Financial Results Conference Call on November 3, 2026 PR··MiscellaneousFlux Power to Host 2027 Fiscal First Quarter Financial Results Conference Call on November 3, 2026
Flux Power Holdings, Inc. (NASDAQ:FLUX), a leading developer of advanced lithium-ion energy storage solutions and fleet intelligence technology, will report its 2027 fiscal first quarter results on Tuesday, November 3, 2026, after market close. Krishna Vanka, Chief Executive Officer, and Kevin Royal, Chief Financial Officer, will host a conference call at 4:30 p.m. ET to discuss the Company’s financial results, followed by a question-and-answer session. Analysts and investors are invited to join the conference call using the following information: Date: Tuesday, Nov. 3, 2026Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)Conference Ca
Victory Capital Dual Lists Its ETFs on Nasdaq Texas PR··FinanceVictory Capital Dual Lists Its ETFs on Nasdaq Texas
Becomes the first ETF issuer to list on Nasdaq TexasSupports strategic growth direction and visibility of its ETF platformVictory Capital Holdings, Inc. (NASDAQ:VCTR) ("Victory Capital" or the "Company") today announced the dual listing of its exchange traded funds (ETFs) on Nasdaq Texas. Victory Capital’s ETFs will maintain their existing ticker symbols, as well as their primary listings on the Nasdaq Stock Market. They will also be the first ETFs to list on Nasdaq Texas."Dual listing on Nasdaq Texas is a strategic step for our growing ETF business, raising the visibility of our products and capabilities, while keeping the trading experience unchanged for our shareholders," said Mannik Dhil